Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8161986 | 0.85 | MAPT (0.45) | MAPT | |
| SCHEMBL25259165 | 0.84 | MAPT (0.32) | MAPT | |
| SCHEMBL9955837 | 0.79 | MAPT (0.31) | MAPT | |
| SCHEMBL4501903 | 0.71 | — | — | |
| SCHEMBL8054703 | 0.71 | CA1 (0.30) | — | |
| SCHEMBL1177456 | 0.70 | — | — | |
| SCHEMBL10618698 | 0.68 | P2RX7 (0.41) | — | |
| SCHEMBL25258771 | 0.67 | — | — | |
| SCHEMBL25101268 | 0.67 | — | — | |
| SCHEMBL6864853 | 0.67 | ALDH1A1 (0.33) | MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230295068-A1 | NOVEL CYCLOALKENONE COMPOUND OR SALT THEREOF | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2023-09-21 | — | — | US | disclosed |
| EP-4194435-A1 | NOVEL CYCLOALKENONE COMPOUND OR SALT THEREOF | Taiho Pharmaceutical Co., Ltd. (JP) | 2023-06-14 | — | — | EP | disclosed |
| CN-116096361-A | Novel cyclic enone compound or salt thereof | 大鹏药品工业株式会社 | 2023-05-09 | — | — | CN | disclosed |
| US-6025323-A | CONFERRING AROMATIC AND THUJONIC NOTES TO PERFUMES | FIRMENICH SA (CH) | 2000-02-15 | — | — | US | disclosed |
| EP-0868502-B1 | USE OF CYCLIC KETONES IN PERFUMERY | FIRMENICH & CIE (CH) | 1999-12-01 | — | — | EP | disclosed |
| EP-0868502-A1 | USE OF CYCLIC KETONES IN PERFUMERY | FIRMENICH SA (CH) | 1998-10-07 | — | — | EP | disclosed |
| WO-1998013447-A1 | USE OF CYCLIC KETONES IN PERFUMERY | FIRMENICH S.A. (CH) | 1998-04-02 | — | — | WO | disclosed |
| EP-0061669-B1 | PROCESS FOR THE PREPARATION OF CYCLOHEXANE-1,3-DIONES, AND SOME BICYCLIC CYCLOHEXANE-1,3-DIONES | BASF Aktiengesellschaft (DE) | 1984-07-25 | — | — | EP | disclosed |
| EP-0061669-A1 | Process for the preparation of cyclohexane-1,3-diones, and some bicyclic cyclohexane-1,3-diones | BASF Aktiengesellschaft (DE) | 1982-10-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230295068-A1 | NOVEL CYCLOALKENONE COMPOUND OR SALT THEREOF | BDNF, SMN1; SMN2, ELAVL1 | MAPT 196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.